C2H3N4SK, orthorhombic, Pnma (no. 62), a = 13.874(2) Å, b = 6.5644(11) Å, c = 6.6911(11) Å, V = 609.39(17) Å3, Z = 4, Rgt(F) = 0.02345, wRref(F2) = 0.0594, T = 296 K
C9H8N2OS, monoclinic, C2/c (no. 15), a = 24.273(5) Å, b = 9.026(2) Å, c = 8.2852(19) Å, β = 108.818(...
The crystal structure of 4-(1-phenyl-1-methylcyclobutyl-3-yl)-2-aminothiazole (C14H16N2S) has been d...
The title compound, K+·C18H14N5O2S3−·C3H7NO·0.5H2O, was obtained in a reaction designed to deliver a...
C12H13KN2O5S, monoclinic, P21/c (no. 14), a = 15.8681(4) Å, b = 7.2173(2) Å, c = 12.8527(4) Å, β = 1...
C5H9BF3KS2, triclinic, P (1) over bar (no. 2), a = 11.9238(5) angstrom, b = 13.6060(5) angstrom, c =...
C4H7BF3KS2, monoclinic, P12(1)/cl (no. 14), a = 14.7374(3) angstrom, b = 9.06121) angstrom, c = 13.5...
C4H7BF3KS2, monoclinic, P121/c1 (no. 14), a = 14.7374(3) Å, b = 9.0612(1) Å, c = 13.5805(2) Å, β = 9...
Potassium hydrotris(2-mercaptothiazolyl)borate, KMt, (1) and potassium hydrotris(2-methimazole), KTm...
The crystal and molecular structure of the title compound, K[C₅H₄N₅O₂S]H₂O, has been determined at r...
R factor = 0.044; wR factor = 0.124; data-to-parameter ratio = 13.0. In the title molecule, C3H5N5O2...
The title compound, C12H20N4O, undergoes a phase transition on cooling. The room-temperature structu...
The title compound, C6H6N6S, crystallized with two independent molecules (A and B) in the asymmetric...
C20H19N5S.C2H6O, monoclinic, P21/c (no. 14), a = 12.1257(14) Å, b = 11.0862(14) Å, c = 16.0280(19) Å...
C8H13N3S2, triclinic, P1̅ (no. 2), a = 7.4803(3) Å, b = 8.4562(3) Å, c = 9.3531(3) Å, α = 67.688(1)°...
C4H2S5, orthorhombic, Pnma (No. 62), a = 13.015(1) Å, b = 9.193(1) Å, c = 6.151(1) Å, V = 735.9 Å3, ...
C9H8N2OS, monoclinic, C2/c (no. 15), a = 24.273(5) Å, b = 9.026(2) Å, c = 8.2852(19) Å, β = 108.818(...
The crystal structure of 4-(1-phenyl-1-methylcyclobutyl-3-yl)-2-aminothiazole (C14H16N2S) has been d...
The title compound, K+·C18H14N5O2S3−·C3H7NO·0.5H2O, was obtained in a reaction designed to deliver a...
C12H13KN2O5S, monoclinic, P21/c (no. 14), a = 15.8681(4) Å, b = 7.2173(2) Å, c = 12.8527(4) Å, β = 1...
C5H9BF3KS2, triclinic, P (1) over bar (no. 2), a = 11.9238(5) angstrom, b = 13.6060(5) angstrom, c =...
C4H7BF3KS2, monoclinic, P12(1)/cl (no. 14), a = 14.7374(3) angstrom, b = 9.06121) angstrom, c = 13.5...
C4H7BF3KS2, monoclinic, P121/c1 (no. 14), a = 14.7374(3) Å, b = 9.0612(1) Å, c = 13.5805(2) Å, β = 9...
Potassium hydrotris(2-mercaptothiazolyl)borate, KMt, (1) and potassium hydrotris(2-methimazole), KTm...
The crystal and molecular structure of the title compound, K[C₅H₄N₅O₂S]H₂O, has been determined at r...
R factor = 0.044; wR factor = 0.124; data-to-parameter ratio = 13.0. In the title molecule, C3H5N5O2...
The title compound, C12H20N4O, undergoes a phase transition on cooling. The room-temperature structu...
The title compound, C6H6N6S, crystallized with two independent molecules (A and B) in the asymmetric...
C20H19N5S.C2H6O, monoclinic, P21/c (no. 14), a = 12.1257(14) Å, b = 11.0862(14) Å, c = 16.0280(19) Å...
C8H13N3S2, triclinic, P1̅ (no. 2), a = 7.4803(3) Å, b = 8.4562(3) Å, c = 9.3531(3) Å, α = 67.688(1)°...
C4H2S5, orthorhombic, Pnma (No. 62), a = 13.015(1) Å, b = 9.193(1) Å, c = 6.151(1) Å, V = 735.9 Å3, ...
C9H8N2OS, monoclinic, C2/c (no. 15), a = 24.273(5) Å, b = 9.026(2) Å, c = 8.2852(19) Å, β = 108.818(...
The crystal structure of 4-(1-phenyl-1-methylcyclobutyl-3-yl)-2-aminothiazole (C14H16N2S) has been d...
The title compound, K+·C18H14N5O2S3−·C3H7NO·0.5H2O, was obtained in a reaction designed to deliver a...
DOI
Add to ORKG